ArticleThe oncologist2026

Second-line treatments for patients with programmed cell death protein 1-refractory cutaneous squamous cell carcinomas: a brief report.

Hisham AlSharif et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.